These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2423422)

  • 41. [Antithrombotic prophylaxis of the complications of arteriosclerosis obliterans].
    Heine H; Norden K; Heinemann L; Stepanauskas M; Schmidt H
    Kardiologiia; 1981 Aug; 21(8):76-80. PubMed ID: 7289389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preliminary experience with defibrotide in severe lower limb ischaemia.
    Gelister JS; James WE; Fox JA
    Haemostasis; 1986; 16 Suppl 1():63-6. PubMed ID: 3754838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of chronic administration of selective betablockers on peripheral circulation of the lower limbs in patients with essential hypertension.
    Novo S; Pinto A; Galati D; Giannola A; Forte G; Strano A
    Int Angiol; 1985; 4(2):229-34. PubMed ID: 2870124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prevention of thromboembolism in patients operated on for hip prosthesis].
    Cremonese M; Rigon N; Ratti G; Pojana A; Todesco A; Sartore A
    Minerva Med; 1988 May; 79(5):367-72. PubMed ID: 3287226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Defibrotide in extracorporeal circulation on healthy rabbits.
    Marsili M; Lorenzi P; Librenti M; Doni L; Benassai C; Martini E; Fabbri LP; Cinotti S; Morfini M; Boncinelli S
    Int J Artif Organs; 1989 Dec; 12(12):749-54. PubMed ID: 2613355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness of defibrotide for prophylaxis of deep venous thrombosis after general surgery: a double-blind, placebo-controlled clinical trial.
    Mozzi E; Chiurazzi D; Germiniani R; Pacini F
    Haemostasis; 1986; 16 Suppl 1():36-8. PubMed ID: 3519382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Preoperative care of microcirculatory vessels in patients with lower limb arteriosclerosis obliterans].
    Kuznetsov MR; Koshkin VM; Karalkin AV; Boldin BV; Rodionov SV; Sergeeva NA; Petukhov EB; Golosnitskiĭ PIu
    Angiol Sosud Khir; 2005; 11(1):19-24. PubMed ID: 16034319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antiplatelet therapy in patients with chronic obliterating diseases of lower-limb arteries].
    Kuznetsov MR; Tepliakov SA; Sizarev AV; Tugdumov BV; Dzhalilova NS
    Angiol Sosud Khir; 2010; 16(1):43-7. PubMed ID: 20635715
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A multicenter study of defibrotide in the prevention of deep venous thrombosis. Final results].
    Gerosa C; Calvani AB; Cornelli U; Dina F; Ferrari PA; Ratti G; Nazzari M
    Minerva Chir; 1989 May; 44(10):1507-16. PubMed ID: 2671797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of defibrotide for prophylaxis of deep venous thrombosis in gynecological surgery: a double-blind, placebo-controlled clinical trial.
    Ciavarella N; Ettorre C; Schiavoni M; Schonauer S; Cicinelli E; Cagnazzo G
    Haemostasis; 1986; 16 Suppl 1():39-41. PubMed ID: 3754834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prevention of deep venous thrombosis with defibrotide in chest surgery. Controlled multicenter study versus heparin].
    Rizzi A; Radaelli F; Pisano M; Orro S; Nazzari M; Ratti G; Giobbe R; Maggi G
    Minerva Med; 1987 Jun; 78(11):745-50. PubMed ID: 3295599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Evaluation of the efficacy of profibrinolytic treatment with defibrotide in the therapy of thrombophlebitis].
    Murgiano GA
    Clin Ter; 1988 Dec; 127(5):355-61. PubMed ID: 2976633
    [No Abstract]   [Full Text] [Related]  

  • 53. Defibrotide normalizes cardiovascular function hampered by established atherosclerosis in the rabbit.
    Rossoni G; Berti F; Trento F; Cattaneo F; Porta R; Pescador R; Ferro L
    Thromb Res; 2000 Jan; 97(2):29-38. PubMed ID: 10688332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prostaglandin E1 in the treatment of chronic ischemia of the extremities].
    Kowal-Gierczak B; Kurzawska-Mielecka M; Czarnacki M
    Pol Arch Med Wewn; 1990 Nov; 84(5):321-7. PubMed ID: 2075125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mechanisms of the positive clinical effect of plasmapheresis for arteriosclerosis obliterans in the lower extremities].
    Kliachkin ML; Osipova OV; Marchenko VB; Shesterikov IN
    Kardiologiia; 1992 Feb; 32(2):68-72. PubMed ID: 1527941
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo effects of defibrotide on platelet c-AMP and blood prostanoid levels.
    Cizmeci G
    Haemostasis; 1986; 16 Suppl 1():31-5. PubMed ID: 3011617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation.
    Chalandon Y; Roosnek E; Mermillod B; Newton A; Ozsahin H; Wacker P; Helg C; Chapuis B
    Biol Blood Marrow Transplant; 2004 May; 10(5):347-54. PubMed ID: 15111934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of deep venous thrombosis in orthopedic surgery: effects of defibrotide.
    Zanasi R; Fioretta G; Ciocia G; Bergonzi M
    Clin Ther; 1988; 10(4):350-7. PubMed ID: 3079005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Use of defibrotide in dystrophic lesions of the lower limb in the varico-phlebitic syndrome].
    Cavalli A; Discalzo L; Dal Bo R; Corno F; Cimarelli S
    Minerva Chir; 1987 Jul; 42(13-14):1199-202. PubMed ID: 3670653
    [No Abstract]   [Full Text] [Related]  

  • 60. Fibrinolytic activity of oral cyclandelate in patients with generalized atherosclerotic vasculopathy: a double-blind study.
    Forconi S; Cappelli R; Guerrini M; Frigerio C; Messa GL; Furesi L
    J Int Med Res; 1990; 18(4):257-65. PubMed ID: 2121564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.